Anticorps Recombinant de lapin anti-BTLA/CD272
BTLA/CD272 Recombinant Antibody for FC, Indirect ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
FC, Indirect ELISA
Conjugaison
Non conjugué
CloneNo.
241318H5
N° de cat : 98096-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
98096-1-PBS cible BTLA/CD272 dans les applications de FC, Indirect ELISA et montre une réactivité avec des échantillons Humain
| Réactivité | Humain |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | Protéine recombinante |
| Nom complet | B and T lymphocyte associated |
| Masse moléculaire calculée | 289 aa, 33 kDa |
| Numéro d’acquisition GenBank | BC107091 |
| Symbole du gène | BTLA |
| Identification du gène (NCBI) | 151888 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Protein A purfication |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. |
Informations générales
BTLA ( B and T lymphocyte attenuator), also known as CD272, is a member of the CD28 superfamily and is a type I membrane glycoprotein identified as an inhibitory receptor (PMID: 33859648). BTLA is extensively expressed in lymph nodes, thymus, and spleen, with little or no expression in organs such as the heart, kidney, brain, and liver (PMID: 33859648). Among immune cells, BTLA is primarily expressed in B and T cells, with higher expression in B cells compared to T cells in the mouse spleen (PMID: 33859648). BTLA plays a crucial role in regulating stimulatory and inhibitory signals in immune responses.





